Imalux out of Cleveland, Ohio received the CE Mark for the Niris 1300e tissue imaging system. The device is used to scan epithelial tissue for signs of disease, essentially like an optical biopsy. It relies on near-infrared optical coherence tomography which doesn’t damage the tissue it’s analyzing, while providing real-time cross-sectional visualization via the attached computer. The probe is sterilizable and can also be used inside a single-use semi-rigid sheath to minimize cleaning between patients.
More from the company:
A major strength of Niris is the ability to scan epithelial tissue … for example, from the kidneys to the urethra, from the mouth to the anus, from the nose to the lungs, and skin. Sixty percent (60%) of all human cancers originate in epithelial tissue less than 1.4 mm below the surface. Niris provides an optical biopsy by visualizing tissue microstructure to a depth of 2.5 mm, where diagnostically important tissue alterations first occur. Other imaging modalities lack the resolution and depth of penetration to identify structural changes that are associated with the earliest stages of cancer and other disease states.
Imaging distance: up to 1.6 mm in tissue
Imaging speed: minimum 8 frames per second
In depth spatial resolution: 10 – 20 μm
real time
Easy to interpret
Site-of-care
Portable
Minimal training required
No costly architectural modifications required
Press release: Imalux® receives CE Mark on its enhanced Niris® 1300e Imaging System and begins worldwide commercial shipments…
Product page: Niris Imaging System…